Systematic review of pharmacologic and non-pharmacologic interventions to manage cognitive alterations after chemotherapy for breast cancer

European Journal of Cancer

Volumn 51, Issue 4, 2015, Pages 437-450

  Chan, Raymond J ^a,b   McCarthy, Alexandra L ^a   Devenish, Jackie ^c   Sullivan, Karen A ^a   Chan, Alexandre ^d,e  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Breast cancer; Chemotherapy; Cognitive function; Cognitive training; Physical activity; Psychostimulants

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DEXMETHYLPHENIDATE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GINKGO BILOBA EXTRACT; METHYLPHENIDATE; MODAFINIL; PSYCHOSTIMULANT AGENT; RECOMBINANT ERYTHROPOIETIN; TAMOXIFEN; CENTRAL STIMULANT AGENT;

ANXIETY; ARTICLE; ATTENTION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; COGNITION; COGNITIVE DEFECT; COGNITIVE THERAPY; DIZZINESS; EXECUTIVE FUNCTION; GINKGO BILOBA; HUMAN; INSOMNIA; LANGUAGE; MEMORY DISORDER; MENTAL CONCENTRATION; MINDFULNESS; NAUSEA; NERVOUSNESS; ORIENTATION; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PHYSICAL ACTIVITY; PHYSICAL MEDICINE; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; STRESS MANAGEMENT; SYSTEMATIC REVIEW; WORKING MEMORY; XEROSTOMIA; YOGA; BREAST NEOPLASMS; COGNITION DISORDERS; EXERCISE; FEMALE; PSYCHOLOGY;

BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; EXERCISE; FEMALE; HUMANS;

EID: 84924985762     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.12.017     Document Type: Review

References (56)

1. T.A. Ahles, J.C. Root, and E.L. Ryan Cancer- and cancer treatment-associated cognitive change: an update on the state of the science J Clin Oncol 30 2012 3675 3686
2. C.E. Jansen, C. Miaskowski, and M. Dodd A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function Cancer 104 2005 2222 2233
3. J.S. Wefel, A.K. Saleeba, A.U. Buzdar, and C.A. Meyers Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer Cancer 116 2010 3348 3356
4. S.R. Jacobs, P.B. Jacobsen, and M. Booth-Jones Evaluation of the Functional Assessment of Cancer Therapy Cognitive Scale with hematopoietic stem cell transplant patients J Pain Symptom Manage 33 2007 13 23
5. Y.T. Cheung, W.K. Chui, and A. Chan Neuro-cognitive impairment in breast cancer patients: pharmacological considerations Crit Rev Oncol Hematol 83 2012 99 111
6. V. Koppelmans, M.M. Breteler, and W. Boogerd Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy J Clin Oncol 30 2012 1080 1086
7. S. Deprez, F. Amant, and A. Smeets Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning J Clin Oncol 30 2012 274 281
8. H.S. Jim, K.M. Phillips, and S. Chait Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy J Clin Oncol 30 2012 3578 3587
9. H.L. McGinty, K.M. Phillips, and H.S. Jim Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis Support Care Cancer 22 2014 2271 2280
10. S. Hines, M.A. Ramis, S. Pike, and A.M. Chang The Effectiveness of psychosocial interventions for cognitive dysfunction in cancer patients who have received chemotherapy: a systematic review Worldviews Evid Based Nurs 11 2014 187 193
11. K. Gehring, J.A. Roukema, and M.M. Sitskoorn Review of recent studies on interventions for cognitive deficits in patients with cancer Expert Rev Anticancer Ther 12 2012 255 269
12. J.S. de Moor, A.B. Mariotto, and C. Parry Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care Cancer Epidemiol Biomarkers Prev 22 2013 561 570
13. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
14. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. In: The Cochrane Collaboration; 2011.
15. M.K. Garcia, J. McQuade, and R. Haddad Systematic review of acupuncture in cancer care: a synthesis of the evidence J Clin Oncol 31 2013 952 960
16. M. Lezek, D. Howieson, E. Bigler, and D. Tranel Neuropsychological assessment 2012 Oxford University Publisher USA
17. K.D. Hodgson, A.D. Hutchinson, C.J. Wilson, and T. Nettelbeck A meta-analysis of the effects of chemotherapy on cognition in patients with cancer Cancer Treat Rev 39 2013 297 304
18. F. Boele, L. Douw, and M. de Groot The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial Neuro Oncol 15 2013 1420 1428
19. P.D. Brown, S. Pugh, and N.N. Laack Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial Neuro Oncol 15 2013 1429 1437
20. L. Capuron, J.F. Gumnick, and D.L. Musselman Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions Neuropsychopharmacology 26 2002 643 652
21. M.M. Cherrier, K. Anderson, and D. David A randomized trial of cognitive rehabilitation in cancer survivors Life Sci 93 2013 617 622
22. K. Gehring, S.Y. Patwardhan, and R. Collins A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor J Neuro Oncol 107 2012 165 174
23. M.M. Goedendorp, H. Knoop, and M.F.M. Gielissen The effects of cognitive behavioral therapy for postcancer fatigue on perceived cognitive disabilities and neuropsychological test performance J Pain Symptom Manage 47 2014 35 44
24. H.J. Green, K.I. Pakenham, and B.C. Headley Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial BJU Int 90 2002 427 432
25. M. Jarden, K. Nelausen, and D. Hovgaard The effect of a multimodal intervention on treatment-related symptoms in patients undergoing hematopoietic stem cell transplantation: a randomized controlled trial J Pain Symptom Manage 38 2009 174 190
26. H. Jim, T. Boyd, and M. Booth-Jones Granulocyte macrophage colony stimulating factor treatment is associated with improved cognition in cancer patients Brain Disord Ther 1 2012 1 10
27. L.E. Lundorff, B.H. Jønsson, and P. Sjøgren Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial Palliat Med 23 2009 731 738
28. G.J. McDougall, H. Becker, and T.W. Acee Symptom management of affective and cognitive disturbance with a group of cancer survivors Arch Psychiatr Nurs 25 2011 24 35
29. B. Oh, P. Butow, and B. Mullan Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial Support Care Cancer 20 2012 1235 1242
30. M. Poppelreuter, J. Weis, and H.H. Bartsch Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy J Psychosoc Oncol 27 2009 274 296
31. A. Doorenbos, B. Given, and C. Given Reducing symptom limitations: a cognitive behavioral intervention randomized trial Psychooncology 14 2005 574 584
32. C.W. Given, A. Sikorskii, and D. Tamkus Managing symptoms among patients with breast cancer during chemotherapy: results of a two-arm behavioral trial J Clin Oncol 26 2008 5855 5862
33. A. Schuurs, and H. Green A feasibility study of group cognitive rehabilitation for cancer survivors: enhancing cognitive function and quality of life Psychooncology 22 2013 1043 1049
34. D.L. Barton, K. Burger, and P.J. Novotny The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 Support Care Cancer 21 2013 1185 1192
35. S.N. Culos-Reed, L.E. Carlson, L.M. Daroux, and S. Hately-Aldous A pilot study of yoga for breast cancer survivors: physical and psychological benefits Psychooncology 15 2006 891 897
36. S. Dolbeault, S. Cayrou, and A. BrÈdart The effectiveness of a psycho-educational group after early-stage breast cancer treatment: results of a randomized French study Psychooncology 18 2009 647 656
37. C.P. Escalante, C. Meyers, and J.M. Reuben A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients Cancer J 20 2014 8 14
38. R.J. Ferguson, B.C. McDonald, and M.A. Rocque Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial Psychooncology 21 2012 176 186
39. S. Kesler, S.M. Hadi Hosseini, and C. Heckler Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors Clin Breast Cancer 13 2013 299 306
40. S. Kohli, S.G. Fisher, and Y. Tra The effect of modafinil on cognitive function in breast cancer survivors Cancer 115 2012 2605 2616
41. E.E. Lower, S. Fleishman, and A. Cooper Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial J Pain Symptom Manage 38 2009 650 662
42. H.G. Mar Fan, M. Clemons, and W. Xu A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer Support Care Cancer 16 2012 577 583
43. E. Miki, T. Kataoka, and H. Okamura Feasibility and efficacy of speed-feedback therapy with a bicycle ergometer on cognitive function in elderly cancer patients in Japan Psychooncology 23 2014 906 913
44. K. Milbury, A. Chaoul, and K. Biegler Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial Psychooncology 22 2013 2354 2363
45. J.A. O'Shaughnessy, S.J. Vukelja, and F.A. Holmes Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy Clin Breast Cancer 5 2005 439 446
46. D. Von Ah, J.S. Carpenter, and A. Saykin Advanced cognitive training for breast cancer survivors: a randomized controlled trial Breast Cancer Res Treat 135 2012 799 809
47. P. Hazell The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder Curr Opin Psychiatry 24 2011 286 290
48. I.M. Janssen, S. Sturtz, and G. Skipka Ginkgo biloba in Alzheimer's disease: a systematic review Wien Med Wochenschr 160 2010 539 546
49. S. Weinmann, S. Roll, and C. Schwarzbach Effects of Ginkgo biloba in dementia: systematic review and meta-analysis BMC Geriatr 10 2010 14
50. A. Jatoi, S.P. Kahanic, and S. Frytak Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs Support Care Cancer 13 2005 66 69
51. Y.T. Cheung, M. Shwe, and Y.P. Tan Cognitive changes in multiethnic Asian breast cancer patients: a focus group study Ann Oncol 23 2012 2547 2552
52. J.S. Wefel, J. Vardy, T.A. Ahles, and S.B. Schagen International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer Lancet Oncol 12 2011 703 708
53. J.A. Suhr, and C. Wei Response expectancies and their potential influence in neuropsychological evaluation P.A. Arnett, Secondary influences on neuropsychological test performance: research findings and practical applications 2013 Oxford University Press New York
54. B.N. Axelrod, R.D. Vanderploeg, and J.A. Schinka Comparing methods for estimating premorbid intellectual functioning Arch Clin Neuropsychol 14 1999 341 346
55. I. Boutron, L. Guittet, and C. Estellat Reporting methods of blinding in randomized trials assessing nonpharmacological treatments PLoS Med 4 2007 e61
56. K.E. Freedland, D.C. Mohr, K.W. Davidson, and J.E. Schwartz Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions Psychosom Med 73 2011 323 335